New Study Reveals Effective Treatment for Children Suffering From Persistent Post-Concussion Syndrome
September 23, 2022 13:51 ET
|
Aviv Clinics
ORLANDO, Fla., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Today, Aviv Clinics highlights a new study published in Scientific Reports showing an effective treatment to heal damaged brain tissue and relieve...
electroCore Strengthens Patent Portfolio with Issuance of Four New U.S. Patents
September 21, 2022 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark...
The Carrick Institute to Host 1-Day Concussion Bootcamp Workshop at 37th World Congress of Sports Medicine
September 20, 2022 14:00 ET
|
Carrick Institute
GUADALAJARA, Mexico, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The Carrick Institute, world leader in clinical neuroscience education, proudly announced today that they will be delivering a 1-day...
Electrocore Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals
September 20, 2022 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 20, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (the “Company”), a commercial-stage bioelectronic medicine company, today announced its plans to hold its fiscal...
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial, Cohort II
September 13, 2022 08:00 ET
|
Odyssey Health, Inc
Las Vegas, NV, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,...
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Reduces Symptoms of Acute Withdrawal in Patients with Opioid Use Disorder
September 07, 2022 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer reviewed...
electroCore to Participate at Upcoming Investor Conferences
September 06, 2022 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Sept. 06, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer,...
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial
August 18, 2022 08:00 ET
|
Odyssey Health, Inc
Las Vegas, NV, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,...
Retired NFL Players, Wives Form Player Advocacy Committee to Help Retired Players in the NFL Concussion Settlement; Class Counsel to Support Efforts
August 16, 2022 10:00 ET
|
Player Advocacy Committee for the NFL Concussion Settlement
WASHINGTON, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Dr. Amy Lewis, chair of the newly-created Player Advocacy Committee and wife of retired NFL player Kenneth Jenkins, announced a collaboration with Chris...
Odyssey Health, Inc. Announces Positive Results from Its Phase I Multi-Day Ascending Dosing for the Treatment of Concussion
August 10, 2022 08:00 ET
|
Odyssey Health, Inc
Las Vegas, NV, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-improving medical products,...